Interstitial gene delivery in human xenograft prostate tumors using titanium metal seeds

Molecular Cancer Therapeutics

Volumn 3, Issue 6, 2004, Pages 655-659

  Jung, Mira ^a   Zhang, Yin ^a   Dimtchev, Alexandre ^a   Subramanian, Manny R ^b   Suthanthiran, Krishman ^b   Dritschilo, Anatoly ^a  

^a GEORGETOWN UNIVERSITY MEDICAL CENTER   (United States)

^b Best Medical International Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA GALACTOSIDASE; CYTOKINE; GREEN FLUORESCENT PROTEIN; METAL; RADIOSENSITIZING AGENT; TITANIUM; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRACHYTHERAPY; CANCER INHIBITION; CONTROLLED STUDY; CYTOMEGALOVIRUS; DRUG EFFICACY; DRUG IMPLANTATION; EXPRESSION VECTOR; FEASIBILITY STUDY; GENE EXPRESSION; GENE VECTOR; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; INTERMETHOD COMPARISON; INTERSTITIUM; MALE; MOUSE; NANOTECHNOLOGY; NONHUMAN; NONVIRAL GENE DELIVERY SYSTEM; PLASMID; PRIORITY JOURNAL; PROMOTER REGION; PROSTATE CANCER; PROSTATE TUMOR; PROTEIN EXPRESSION; REPORTER GENE; TISSUE DISTRIBUTION; TUMOR XENOGRAFT;

ANIMALS; CELL LINE, TUMOR; CYTOKINES; GENE THERAPY; GENE TRANSFER TECHNIQUES; GENES, REPORTER; GENETIC VECTORS; HUMANS; MALE; MICE; MICE, NUDE; NEOPLASM TRANSPLANTATION; PROSTATIC NEOPLASMS; TITANIUM; TRANSPLANTATION, HETEROLOGOUS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 4444239953     PISSN: 15357163     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Jain RK. Delivery of molecular and cellular medicine to solid tumors. Microcirculation 1997;4:1-23.
2. Verma IM, Somia N. Gene therapy - promises, problems and prospects. Nature 1997;18:239-42.
3. Nabel GJ. Development of optimized vectors for gene therapy. Proc Natl Acad Sci USA 1999;19:324-6.
4. Williams DA, Baum C. Medicine. Gene therapy - new challenges ahead. Science 2003;17:400-1.
5. Wu Q, Mahendran R, Esuvaranathan K. Nonviral cytokine gene therapy on an orthotopic bladder cancer model. Clin Cancer Res 2003;9: 4522-8.
6. Mauceri HJ, Hanna NN, Beckett MA, et al. Combined effects of angiostatin and ionizing radiation in antitumor therapy. Nature 1998;16: 287-91.
7. Shea LD, Smiley E, Bonadio J, Mooney DJ. DNA delivery from polymer matrices for tissue engineering. Nat Biotechnol 1999;17:551-4.
8. Labhasetwar V, Bonadio J, Goldstein S, Chen W, Levy RJ. A DNA controlled-release coating for gene transfer: transfection in skeletal and cardiac muscle. J Pharm Sci 1998;87:1347-50.
9. Ledley FD. Pharmaceutical approach to somatic gene therapy. Pharm Res 1996;13:1595-614.
10. Bonadio J, Smiley E, Patil P, Goldstein S. Localized, direct plasmid gene delivery in vivo: prolonged therapy results in reproducible tissue regeneration. Nat Med 1999;5:753-9.
11. Ghivizzani SC, Lechman ER, Kang R, et al. Direct adenovirus-mediated gene transfer of interleukin 1 and tumor necrosis factor α soluble receptors to rabbit knees with experimental arthritis has local and distal anti-arthritic effects. Proc Natl Acad Sci USA 1998;95:4613-8.
12. Kawasaki ES, Ladner MB, Wang AM, et al. Molecular cloning of a complementary DNA encoding human macrophage-specific colony-stimulating factor (CSF-1). Science 1985;230:291-6.
13. McDermott MW, Sneed PK, Gutin PH. Interstitial brachytherapy for malignant brain tumors. Semin Surg Oncol 1998;14:79-87.
14. Suthanthiran K. Device and method for encapsulating radioactive materials. United States patent US 4891165. 1990.
15. Weichselbaum RR, Hallahan DE, Sukhatme VP, Kufe DW. Gene therapy targeted by ionizing radiation. Int J Radiat Oncol Biol Phys 1992; 24:565-7.
16. Weichselbaum RR, Hallahan DE, Beckett MA, et al. Gene therapy targeted by radiation preferentially radiosensitizes tumor cells. Cancer Res 1994;54:4266-9.
17. Old LJ. Tumor necrosis factor (TNF). Science 1985;230:630-2.
18. Chmura SJ, Advani SJ, Kufe DW, Weichselbaum RR. Strategies for enhancing viral-based gene therapy using ionizing radiation. Radiat Oncol Invest 1999;7:261-9.
19. Weichselbaum RR, Kufe DW, Hellman S, et al. Radiation-induced tumor necrosis factor-α expression: clinical application of transcriptional and physical targeting of gene therapy. Lancet Oncol 2002;3:665-71.
20. Sersa G, Willingham V, Milas L. Anti-tumor effects of tumor necrosis factor alone or combined with radiotherapy. Int J Cancer 1988; 42:129-34.